March 6 UCB SA:
* Announced on Saturday that new Cimzia (Certolizumab Pegol) demonstrated statistically and clinically significant improvements for patients with moderate-to-severe chronic plaque psoriasis
Source text: bit.ly/2mKFxD3
Further company coverage: (Gdynia Newsroom)
UPDATE 1-CVS's Omnicare to pay $23 million to resolve U.S. kickback case
BOSTON, May 26 CVS Health Corp's Omnicare unit has agreed to pay $23 million to resolve a whistleblower lawsuit alleging that it took kickbacks from a drugmaker to promote two antidepressants, according to settlement papers released on Friday.